Search for more Public Notices in your area
SYMBIOSIS PHARMACEUTICAL SERVICES LIMITED
General

SYMBIOSIS PHARMACEUTICAL SERVICES LIMITED (the "Company") Company Number: SC373596 Purchase of own shares out of capital

Notice ID: GLA1831737

Notice effective from
1st September 2020 to 1st October 2020

SYMBIOSIS PHARMACEUTICAL SERVICES LIMITED (the "Company") Company Number: SC373596 Purchase of own shares out of capital Notice is hereby given by the Company, pursuant to section 719 of the Companies Act 2006, that on 27 August 2020 the Company passed a special resolution approving a payment out of capital in accordance with section 716 of the Companies Act 2006 for the purpose of the Company purchasing 300,461 ordinary shares of £0.01 each in the capital of the Company; the amount of permissible capital payment (as defined by section 710 of the Companies Act 2006) for the shares in question is £51,378.83; the directors' statement and the auditor's report required by section 714 of the Companies Act 2006 in connection with the proposed payment out of capital are available for inspection at Unit 10 Scion House, Stirling University Innovation Park, Stirling, FK9 4NF; and any creditor of the Company may at any time within the period of five weeks immediately following 27 August 2020 apply to the court under section 721 of the Companies Act 2006 for an order preventing the payment out of capital.

Attachments

GLA1831737.pdf Download

Comments


or Register to leave a comment and/or receive comment alerts.

Related notices